Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Feb 17, 2024 1:47pm
365 Views
Post# 35885988

Weekend thoughts

Weekend thoughts

This weekend is annoyingly long.
Monday markets closed both Cabasa & Nas.
Regardless, my weekend update...FWIW .
Regsrding the accumulated deficit. I agree with that sentiment & math 100%.
On a fire sale buyout, ( not what I'm predicting, just commenting on the math), ONC would be worth near $5 USd / share, to the aquiring company.
Even @ worst case 50 cents on the dollar, still double precent day trading price.
Now add on the upside value of now 3 advanced trials with Roche. That being cotherapy with tecentriq. 

Progress & fast track ready, bio markers identified , etcnwith MBc.
Oncolyitics biotech Pelareorep  could become a blockbuster immunotherapy for cancer treatments.
Creating a corporate value certainly more than just one $1billlion.
As notable mentioned , the tax loss has real value against future corporate profits.
What we don't know is how much the accountants & lawyers would alllow to be paid to aquiring that opportunity.
onc has $40 million or so in cash, zero debt & a fully operational manufacturing arrangement.
What is Onc worth?
Assuming they get phase 3 underway, And the long awaited Bracelet ovrall survival comes out ahead of expected, Then Pela then shows a much stronger clinical benefit & much higher uoside of potential value.
That being a licensing agreement, buyout or some other partnership business deal.
in simple terms. Longer is not a bad thing, if the reults continue to improve.
We know withiut it being said directly, they are all waiting to see O.S. Results from bracelet.
The irony being the longer the paitents live , the better for Pela, yet people get more impatient.
Are there negotiations with Roche? 

We know for sure, Roche is happy with the most recent anal cancer trial progress. If not they would not  agree to proceed. 

Many good indicators on the clinical side, yet some choose to focus on only the negatives.
Obviius signs of an intentional " team" of bashes. My guess some are same people with mutiple handles.
Tam for example is either a " bot" or a complete illiterate. None of his comments even match @ questions or in place topics.
armedescape has destroyed probably 3 separate chat sites with his irrelevant & poposterous ramblings.
My question has always been motivation?
Regardless of my stock bashing conspiracy theories, the SP is trading well under even a complete collapse & sale , price.
The lowest & most conservative has a $5 usd SP, with RBC having an $18ps upside on phase 3 initiation or a licensing deal.
im well aware , the PanCan cancellation was a kick in the belly for ONC.
How they recover will be interesting to witness. With 2 phase 3 enrolment plans announced to begin in next few months, that answer must come soon.
Buyout? Licensing deal? Partership? New business arrangement un yet thought of, by us observers?
The existing $$ model can not go on much longer. Let's hope for the best.....
With the recent science reenforcing now a third arm within goblet. Obviously good news.



 

<< Previous
Bullboard Posts
Next >>